Clinical Evidence

Corneal Epithelial Defects

Multiple studies demonstrate that amniotic membrane transplantation promotes rapid epithelialization in persistent corneal epithelial defects resistant to conventional therapy.

Sources: Ophthalmology journals, 2015-2023

Corneal Ulcers

Clinical trials have shown improved healing rates and reduced inflammation in neurotrophic and bacterial corneal ulcers treated with amniotic membrane.

Sources: Cornea, American Journal of Ophthalmology

Limbal Stem Cell Deficiency

Amniotic membrane serves as a substrate for limbal stem cell transplantation and has been shown to support epithelial regeneration in LSCD cases.

Sources: Ocular Surface journals

Pterygium Surgery

Amniotic membrane grafting following pterygium excision shows lower recurrence rates compared to bare sclera technique, with improved cosmetic outcomes.

Sources: British Journal of Ophthalmology

Chemical Burns

Early intervention with amniotic membrane in acute chemical burns helps reduce inflammation and promotes epithelial healing.

Sources: Ophthalmology

Wound Care

Beyond ophthalmology, amniotic membrane is used in chronic wound management, including diabetic foot ulcers and venous stasis ulcers.

Sources: Wound Repair and Regeneration

Extracellular Matrix Scaffold

Amniotic membrane provides a natural three-dimensional scaffold that supports cell migration, attachment, and proliferation. The collagen-rich matrix mimics native tissue architecture.

Anti-Scarring Properties

Contains tissue inhibitors of matrix metalloproteinases (TIMPs) that reduce collagen deposition and scarring. The basement membrane also modulates growth factor activity.

Anti-Inflammatory Effects

Secretes anti-inflammatory cytokines including IL-10 and modulates the immune response, reducing inflammatory cell infiltration at the wound site.

Growth Factor Delivery

Contains multiple growth factors (EGF, bFGF, KGF, VEGF) that are released during implantation and support tissue regeneration and angiogenesis.